Trexquant Investment LP boosted its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 37.5% during the second quarter, Holdings Channel reports. The firm owned 3,300 shares of the company’s stock after buying an additional 900 shares during the period. Trexquant Investment LP’s holdings in Henry Schein were worth $604,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of HSIC. Vanguard Group Inc. boosted its position in Henry Schein by 1.7% in the first quarter. Vanguard Group Inc. now owns 7,849,455 shares of the company’s stock valued at $1,334,173,000 after buying an additional 127,660 shares during the period. BlackRock Inc. boosted its position in Henry Schein by 2,999.6% in the first quarter. BlackRock Inc. now owns 5,595,279 shares of the company’s stock valued at $951,028,000 after buying an additional 5,414,761 shares during the period. State Street Corp boosted its position in Henry Schein by 1.3% in the first quarter. State Street Corp now owns 3,675,674 shares of the company’s stock valued at $624,760,000 after buying an additional 48,469 shares during the period. Mackenzie Financial Corp boosted its position in Henry Schein by 4.7% in the first quarter. Mackenzie Financial Corp now owns 1,728,230 shares of the company’s stock valued at $293,747,000 after buying an additional 76,794 shares during the period. Finally, JPMorgan Chase & Co. boosted its position in Henry Schein by 12.4% in the first quarter. JPMorgan Chase & Co. now owns 1,515,861 shares of the company’s stock valued at $257,650,000 after buying an additional 167,213 shares during the period. Institutional investors own 90.87% of the company’s stock.

Shares of Henry Schein, Inc. (NASDAQ HSIC) opened at 170.58 on Friday. Henry Schein, Inc. has a 12 month low of $146.23 and a 12 month high of $186.99. The stock has a market cap of $13.49 billion, a P/E ratio of 24.93 and a beta of 1.09. The stock’s 50 day moving average is $181.54 and its 200 day moving average is $175.12.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, August 8th. The company reported $1.75 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.02. The firm had revenue of $3.06 billion during the quarter, compared to the consensus estimate of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The firm’s revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.64 earnings per share. Analysts predict that Henry Schein, Inc. will post $7.28 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece was reported by Daily Political and is the property of of Daily Political. If you are accessing this piece on another site, it was illegally stolen and reposted in violation of U.S. and international copyright law. The legal version of this piece can be read at https://www.dailypolitical.com/2017/08/12/trexquant-investment-lp-has-604000-stake-in-henry-schein-inc-hsic.html.

Several research analysts have commented on HSIC shares. Zacks Investment Research cut shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Wednesday. Northcoast Research upgraded shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price target for the company in a report on Monday, August 7th. BidaskClub cut shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Wednesday, August 2nd. Jefferies Group LLC reiterated a “hold” rating and set a $177.00 price target on shares of Henry Schein in a report on Friday, July 21st. Finally, Piper Jaffray Companies started coverage on shares of Henry Schein in a report on Monday, June 12th. They set a “neutral” rating and a $200.00 price target for the company. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and seven have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $185.56.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.